Skip to main content
SpringerLink
Log in
Book cover

Terapia delle malattie neurologiche pp 539–546Cite as

Miopatie infiammatorie

  • Chapter

  • 1072 Accesses

Riassunto

Le miopatie infiammatorie comprendono un gruppo eterogeneo di malattie muscolari acquisite, ad andamento subacuto o cronico, caratterizzate da ipostenia prevalentemente prossimale e dalla presenza di infiltrati infiammatori alla biopsia muscolare [1]. Sono le più diffuse miopatie acquisite e potenzialmente trattabili, sia nell’età adulta sia fra i bambini. L’incidenza annuale riportata varia da 2,2 a 7,7/1.000.000 e la prevalenza da 10 a 63/1.000.000 [1, 2].

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   29.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   39.95
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliografia

  1. Engel AG, Hohfeld R. The polymyositis and dermatomyositis syndromes. In: Engel AG, Franzini-Armstrong C (eds). Myology 3rd ed. New York Mc-Graw-Hill 2004; 1321–1366.

    Google Scholar 

  2. Mastaglia FL, Garlepp MJ, Phillips BA et al. Inflammatory myopathies: clinical, diagnostic and therapeutic aspects. Muscle Nerve 2003; 27:407–425.

    Article  PubMed  Google Scholar 

  3. Hohlfeld R and Dornmair K. Revisiting the immunopathogenesis of the inflammatory myopathies. Editorial. Neurology 2007; 69:1966–1967.

    Google Scholar 

  4. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1974; 292: 344.

    Google Scholar 

  5. Emslie-Smith AM, Engel AG. Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol 1990; 27:343–356.

    Article  CAS  PubMed  Google Scholar 

  6. Dalakas MC. Immunopathogenesis of inflammatory myopathies. Ann Neurol 1995; 37:S74–S86.

    Article  PubMed  Google Scholar 

  7. Hohfeld R, Engel AG. The immunobiology of muscle. Immmunol Today 1994; 15:269–274.

    Article  Google Scholar 

  8. Greenberg SA. Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications. Neurology 2007; 69:2008–2019.

    Article  PubMed  Google Scholar 

  9. Mantegazza R, Andreetta F, Bernasconi P et al. Analysis of T cell receptor repertoire of muscle infiltrating T lymphocytes in polymyositis: restricted V a/b rearrangements may indicate antigen-driven selection. J Clin Invest 1993; 91:2880–2886.

    Article  CAS  PubMed  Google Scholar 

  10. Amemiya K, Granger RP, Dalakas MC. Clonal restriction of TR-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persisit over time: studies in repeated muscle biopsies. Brain 2000; 123:2030–2039.

    Article  PubMed  Google Scholar 

  11. Needham M, Mastaglia FL. Sporadic inclusion body myositis: a continuing puzzle. Neuromuscular Disorders 2008; 18:6–16.

    Article  CAS  PubMed  Google Scholar 

  12. Askanas V, King Engel W. Inclusion-body myositis, a multifactorial muscle disease associated with aging: current concept and pathogenesis. Current Opinion in Rheumatology 2007, 19: 550–559.

    Article  PubMed  Google Scholar 

  13. Hengstman GJD. Advances in the immunopathophysioloogy of the idiopathic inflammatory myopathies: not as simple as suspected. Curr Rheumatol Rep 2007; 9: 280–285.

    Article  CAS  PubMed  Google Scholar 

  14. Alexanderson H and Lundberg IE. Inflammatory muscole disease: clinical presentation and assessment of patient. Curr Rheumatol Rep 2007; 9: 273–279.

    Article  CAS  PubMed  Google Scholar 

  15. Needham M, Mastaglia FL. Inclusion body myositis: current pathogenetic concept and diagnostic and therapeutic approaches. Lancet Neurol 2007; 6:620–631.

    Article  PubMed  Google Scholar 

  16. Mantegazza R, Bernasconi P, Confalonieri P et al. Inflammatory myopathies and systemic disorders: a review of immunopathogenetic mechanisms and clinical features. J Neurol 1997; 244:277–287.

    Article  CAS  PubMed  Google Scholar 

  17. Dalakas MC. Inflammatory myopathies. Recent advances in pathogenesis and therapy. In: Pourmand R and Harati Y (eds). Neuromuscular disorders. Philadelphia: Lippincott Williams & Wilkins, 2001.

    Google Scholar 

  18. Callen JP. Dermatomyositis. Lancet 2000; 355: 53–57.

    Article  CAS  PubMed  Google Scholar 

  19. Brown H, Steven A. Myositis and malignancy: is there a true association? Hosp Med 1999; 60:51–53.

    CAS  PubMed  Google Scholar 

  20. Dalakas MC. Virus-related muscle diseases. In: Engel AG, Franzini-Armstrong C (eds). Myology. 3rd ed. New York, Mc-Graw-Hill 2004; 51:1389–1417.

    Google Scholar 

  21. Banker BQ, Engel AG. Other inflammatory myopathies. In: Engel AG, Franzini-Armstrong C (eds). Myology. 3rd ed. New York: Mc-Graw-Hill; 2004; 53:1445–1472.

    Google Scholar 

  22. Mozaffar T, Lopate G, Pestronk A. Clinical correates of granulomas in muscle. J Neurol 1998; 245:519–524.

    Article  CAS  PubMed  Google Scholar 

  23. Gherardi RK, Coquet, Cherin P, Authier FJ et al. Macrophagic Myofasciitis: an emerging entity. Lancet 1998; 352:347–352.

    Article  CAS  PubMed  Google Scholar 

  24. Kissel JT. Polymyositis. Not a unicorn or mythological beast but maybe a duck? Editorial. Neurology 2008; 70:414–415.

    Google Scholar 

  25. Hoogendijk JE, Amato AA, Lecky BR, et al. 119th ENMC International Workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of IBM. Neuromusc Disord 2004; 14:337–345.

    Article  PubMed  Google Scholar 

  26. Mimori T, Imura Y, Nakashima R and Yoshifuji H. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance. Curr Opin Rheumatol 2007; 19:523–529.

    Article  PubMed  Google Scholar 

  27. Kuo GP end Carino JA. Skeletal muscle imaging and inflammatory myopathies. Cur Opin Rheumatol 2007; 19:530–535.

    Article  Google Scholar 

  28. Feldman BM, Rider LG, Reed AM et al. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 2008; 371:2201–2212.

    Article  PubMed  Google Scholar 

  29. Greenberg SA. Inflammatory myopathies: evaluation and management. Semin Neurol 2008; 28:241–249.

    Article  PubMed  Google Scholar 

  30. Antozzi C, Confalonieri P, Mantegazza R et al. Emerging treatments in myopathies. Eur Neurol 1997; 38:222–229.

    Article  CAS  PubMed  Google Scholar 

  31. Miller F, Walsh Y, Saminaden S, Lecky B, Winer J. Randomized double blind trial of methotrexate and steroids compared with azathioprine and steroids in the treatment of idiopatic inflammatyory myopathy. J Neurol Sci 2002; 199: S53.

    Google Scholar 

  32. Miller FW, Leitman SF, Cronin ME, Hicks JE, Leff RL, Wesley R, Fraser DD, Dalakas M, Plotz PH. Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis. N Engl J Med 1992; 326:1380–1384.

    CAS  PubMed  Google Scholar 

  33. Grau JM, Herrero C, Casademont J, Fernandez-Sola J, Urbano-Marquez A. Cyclosporin A as first choiche for dermatomyositis. J Rheumatol 1994; 21:381–382.

    CAS  PubMed  Google Scholar 

  34. Cherin P, Pelletier S, Teixeira A, Laforet P, Genereau T, Simon A, Maisonobe T, Eymard B, Herson S. Results and long-term follow-up of intravenous immunoglobulin infusion in chronic refrectory polymyositis: an open study with thirty-five adult patients. Arthritis Rheum 2002; 46:467–474.

    Article  CAS  PubMed  Google Scholar 

  35. Dalakas MC. Therapeutical targets in patients with inflammatory myopathies: present approaches and look to the future. Neuromuscul Disord 2006; 16:223–236.

    Article  PubMed  Google Scholar 

  36. Dalakas MC. Advances in the immunobiology and treatment of inflammatory myopathies. Curent Rheumatology Report 2007; 9:291–297.

    Article  CAS  Google Scholar 

  37. Dalakas MC. Clinical, immunopathologic, and therapeutic considerations of inflammatory myopathies. Clinical Neuropharmacology 1992; 15:327–351.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Neuroimmunologia, Fondazione Istituto Neurologico “C. Besta”, Milano

    Paolo Confalonieri

Authors
  1. Paolo Confalonieri
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Italia

About this chapter

Cite this chapter

Confalonieri, P. (2009). Miopatie infiammatorie. In: Terapia delle malattie neurologiche. Springer, Milano. https://doi.org/10.1007/978-88-470-1120-5_41

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-1120-5_41

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-1119-9

  • Online ISBN: 978-88-470-1120-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation